Advanced Search

Study Preview



Study Title and Description

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Author Grebely J., Dalgard O., Conway B., Cunningham EB., Bruggmann P., Hajarizadeh B., Amin J., Bruneau J., Hellard M., Litwin AH., Marks P., Quiene S., Siriragavan S., Applegate TL., Swan T., Byrne J., Lacalamita M., Dunlop A., Matthews GV., Powis J., Shaw D., Thurnheer MC., Weltman M., Kronborg I., Cooper C., Feld JJ., Fraser C., Dillon JF., Read P., Gane E., Dore GJ.
Country The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
Year 2018
Numbers Pubmed ID: 29310928

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.